-+ 0.00%
-+ 0.00%
-+ 0.00%

Exozymes CEO Michael Heltzen reports $59,978 common share purchase

PUBT·09/02/2026 23:44:28
Listen to the news
Exozymes CEO Michael Heltzen reports $59,978 common share purchase
  • Exozymes CEO Michael Heltzen reported open-market purchases totaling 9,696 common shares at prices from USD 6.4 to USD 7.6.
  • Directly held stake rose to 14,708 common shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exozymes Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-041290), on September 02, 2026, and is solely responsible for the information contained therein.